RMP-7: Began Phase II trial in the U.K. in 50 patients to test tumor response and clinical status

Alkermes Inc. (ALKS), Cambridge, Mass. Product: RMP-7, which triggers a brief relaxation of the blood-brain barrier at the blood vessel wall, in combination with carboplatin chemotherapy Indication: R...